• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

2-Bromo-5-propionylphenylacetic Acid: A Comprehensive Overview

2-Bromo-5-propionylphenylacetic acid, identified by the CAS number 159430-77-0, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound, characterized by its bromine substituent at the second position and a propionyl group at the fifth position on the phenyl ring, has garnered attention due to its potential applications in drug design and synthesis. Recent studies have highlighted its role as an intermediate in the synthesis of bioactive molecules, particularly those with anti-inflammatory and antioxidant properties.

The structure of 2-Bromo-5-propionylphenylacetic acid consists of a phenyl ring substituted with bromine and a propionyl group, along with an acetic acid moiety. This unique arrangement allows for diverse reactivity, making it a versatile building block in organic synthesis. Researchers have explored its use in constructing heterocyclic compounds, which are often key components in pharmaceutical agents. For instance, a study published in 2023 demonstrated the utility of this compound in synthesizing isoquinoline derivatives, known for their antitumor activity.

In terms of synthesis, 2-Bromo-5-propionylphenylacetic acid can be prepared via various methods, including nucleophilic aromatic substitution and Friedel-Crafts acylation. These methods have been optimized to enhance yield and purity, ensuring its suitability for large-scale production. The compound's stability under various reaction conditions has also been extensively studied, making it a reliable reagent in multi-step synthetic processes.

The pharmacological potential of 2-Bromo-5-propionylphenylacetic acid lies in its ability to modulate cellular pathways associated with inflammation and oxidative stress. Preclinical studies have shown that derivatives of this compound exhibit potent anti-inflammatory effects by inhibiting cyclooxygenase (COX) enzymes. Additionally, its antioxidant properties suggest potential applications in mitigating oxidative damage associated with neurodegenerative diseases.

Recent advancements in computational chemistry have further elucidated the molecular interactions of 2-Bromo-5-propionylphenylacetic acid. Molecular docking studies reveal that the bromine substituent plays a crucial role in enhancing the compound's binding affinity to target proteins. This insight has guided the design of more effective drug candidates, underscoring the importance of structural modifications in optimizing biological activity.

In conclusion, 2-Bromo-5-propionylphenylacetic acid, with its distinctive chemical structure and versatile reactivity, continues to be a focal point in chemical research. Its role as an intermediate in drug development and its promising pharmacological properties make it a valuable asset in the pursuit of novel therapeutic agents. As research progresses, further insights into its mechanisms and applications are expected to emerge, solidifying its position as an essential compound in modern chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)